A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

NCT06612268 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Etavopivat
DRUG: Placebo

Sponsor

Novo Nordisk A/S